Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Jesduvroq® (daprodustat) – Withdrawal from the market

December 19, 2024 - GSK announced the decision to voluntarily withdraw Jesduvroq (daprodustat) from the US marketplace due to business reasons. The withdrawal is not due to any safety or efficacy issues.  

Download PDF

Rx navigation